Autacoids And Related Drug Market Report 2026

Autacoids And Related Drug Market Overview

• Autacoids And Related Drug market size has reached to $52.81 billion in 2025 • Expected to grow to $70.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Rising Demand For Vascular And Anti-Inflammatory Therapies • Market Trend: Improving Access To Allergy Medications Through OTC Availability • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Autacoids And Related Drug Market?

Autacoids and related drugs are biologically active substances produced by the body that act locally to regulate physiological functions, typically within a specific tissue or organ. They are involved in inflammation, smooth muscle contraction, immune responses, and blood flow regulation. Autacoids exert their effects by binding specific receptors on target cells, initiating signaling pathways that influence cellular activity. The main types of autacoids and related drug include histamines, prostaglandins, leukotrienes, serotonin, and bradykinin. Histamines are chemicals released during allergic reactions that cause symptoms such as itching, swelling, and increased stomach acid. They are targeted in treatments for allergies and acid-related conditions. Drugs targeting these autacoids can be administered through various routes, including oral, injectable, topical, intranasal, and inhalation. These treatments are used for a variety of applications, such as cardiovascular disorders, inflammatory diseases, respiratory disorders, allergies, and gastrointestinal conditions. The primary end-users of these treatments include hospitals, clinics, homecare settings, and pharmacies.

What Is The Autacoids And Related Drug Market Growth Forecast?

The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $70.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to precision pharmacology adoption, receptor-targeted drug development, chronic disease management growth, outpatient treatment expansion, combination therapy usage. Major trends in the forecast period include expanding use in inflammatory disease management, increased focus on receptor-specific drug action, growing demand for targeted autacoid modulators, rising use in cardiovascular and respiratory care, increased adoption of combination therapies.

Global Autacoids And Related Drug Market Segmentation

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin 2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation 3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders 4) By End User: Hospitals, Clinics, Homecare, Pharmacies Subsegments: 1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists 2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2α (PGF2α) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs 3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors 4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators 5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

What Is The Driver Of The Autacoids And Related Drug Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of autacoids and related drugs market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary heart disease, heart failure, stroke, and hypertension. The increasing prevalence of cardiovascular diseases is primarily attributed to poor diet, as the excessive consumption of saturated fats, trans fats, added sugars, and sodium contributes to high blood pressure, obesity, and elevated cholesterol levels, all of which are major risk factors for heart-related conditions. Autacoids and related drugs enhance cardiovascular health by modulating vascular tone and inflammation, crucial in conditions such as hypertension and heart failure. The agents targeting pathways involving nitric oxide, endothelin, and prostacyclin help restore endothelial function, promoting vasodilation and reducing vascular resistance. For instance, in September 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, there were 17.9 million deaths from cardiovascular diseases. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the autacoids and related drugs industry.

Key Players In The Global Autacoids And Related Drug Market

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

Global Autacoids And Related Drug Market Trends and Insights

Major companies operating in autacoids and related drugs are focusing on developing innovative products, such as antihistamines, to enhance therapeutic efficacy, reduce side effects, and address emerging allergic and inflammatory conditions with greater precision and safety. Antihistamines are medications that block the effects of histamine, a chemical released by your immune system during an allergic reaction. For instance, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceuticals company, launched Bilastine as an over-the-counter (OTC) medicine in Germany, marking a significant step in improving access to effective allergy treatments. The 20 mg blasting tablets offer a non-sedating, second-generation antihistamine solution for patients suffering from allergic symptoms such as hay fever and urticaria.

What Are Latest Mergers And Acquisitions In The Autacoids And Related Drug Market?

In May 2024, Incyte Corporation, a US-based biopharmaceutical company, acquired Escient Pharmaceuticals Inc. for approximately $750 million. With this acquisition, Incyte aims to expand its immunology portfolio and accelerate the development of novel treatments for pruritus and other inflammatory disorders by integrating Escient Pharmaceuticals' innovative pipeline of first-in-class, small molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs). Escient Pharmaceuticals Inc. is a US-based biotechnology company developing novel therapeutics targeting autacoid-related pathways.

Regional Insights

North America was the largest region in the autacoids and related drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Autacoids And Related Drug Market?

The autacoids and related drug market consists of sales of biogenic amines, polypeptide autacoids, lipid-derived autacoids, and leukotrienes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Autacoids And Related Drug Market Report 2026?

The autacoids and related drug market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the autacoids and related drug industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.